Detalhe da pesquisa
1.
Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity.
Cell
; 176(6): 1265-1281.e24, 2019 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30827681
2.
Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemias.
Nat Immunol
; 22(4): 520-529, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33753942
3.
MEN1 mutations mediate clinical resistance to menin inhibition.
Nature
; 615(7954): 913-919, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36922589
4.
Author Correction: Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemias.
Nat Immunol
; 22(11): 1465, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34522041
5.
Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AML.
Cell
; 151(2): 344-55, 2012 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-23063124
6.
Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL.
Blood
; 143(16): 1616-1627, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38215395
7.
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need.
Blood
; 141(6): 567-578, 2023 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36399715
8.
High-dimensional genomic feature selection with the ordered stereotype logit model.
Brief Bioinform
; 23(6)2022 11 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36184192
9.
Long-term outcomes in patients with relapsed or refractory hairy cell leukemia treated with vemurafenib monotherapy.
Blood
; 140(25): 2663-2671, 2022 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35930750
10.
TET2-mutant clonal hematopoiesis and risk of gout.
Blood
; 140(10): 1094-1103, 2022 09 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35714308
11.
Long-term outcomes for ibrutinib-rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial.
Blood
; 140(2): 112-120, 2022 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35427411
12.
Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia.
Blood
; 140(21): 2228-2247, 2022 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36130297
13.
Psychological mobile app for patients with acute myeloid leukemia: A pilot randomized clinical trial.
Cancer
; 129(7): 1075-1084, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36655338
14.
Anti-SARS-CoV-2 activity of targeted kinase inhibitors: Repurposing clinically available drugs for COVID-19 therapy.
J Med Virol
; 95(1): e28157, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36117402
15.
Clonal evolution of acute myeloid leukemia with FLT3-ITD mutation under treatment with midostaurin.
Blood
; 137(22): 3093-3104, 2021 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33598693
16.
Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 study.
Blood
; 137(13): 1792-1803, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33024987
17.
Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 21(5): 503-513, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37156478
18.
Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management.
Am J Hematol
; 98(3): 502-526, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36594187
19.
Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/KMT2A.
Proc Natl Acad Sci U S A
; 117(42): 26340-26346, 2020 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33020282
20.
Venetoclax combination therapy in acute myeloid leukemia and myelodysplastic syndromes.
Curr Opin Hematol
; 29(2): 63-73, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34966123